Microenvironments for self-assembly of islet organoids from stem cells differentiation
AssigneeThe Research Foundation for The State University of New York
InventorsSha Jin, Kaiming Ye, Huanjing Bi
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Research Foundation for The State University of New York
InventorsSha Jin, Kaiming Ye, Huanjing Bi
Estimating the term…
Human pluripotent stem cells (hPSCs) are promising cell source to produce therapeutic endocrine cells for diabetes treatment. A gel solution made by decellularized tissue-specific extracellular matrix (dpECM) significantly promotes three-dimensional (3D) islet-like organogenesis during induced hPSC differentiation into endocrine lineages. Islet organoids are self-organized even in a two-dimensional (2D) culture mode. Cells derived from hPSCs differentiated on such ECM coated substrates exhibit similar cellular composition to native pancreatic islets. These cells express islet signature markers insulin, PDX-1, C-peptide, MafA, glucagon, somatostatin, and pancreatic polypeptide, and secrete more insulin in response to glucose level compared to a traditional matrix substrate (Matrigel). The dpECM facilitates generating more C-peptide+/glucagon− cells rather than C-peptide+/glucagon+ cells. Remarkably, dpECM also facilitated intra-organoid vascularity by generating endothelial cells and pericytes. Furthermore, dpECM niches also induced intra-organoid microvascularization during pancreatic differentiation.
A synthetic pancreatic organoid, comprising:
A synthetic pancreatic organoid, comprising:
Dependencies are inferred from the claim text.